These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26603637)

  • 41. SHANK3 Regulates Intestinal Barrier Function Through Modulating ZO-1 Expression Through the PKCε-dependent Pathway.
    Wei SC; Yang-Yen HF; Tsao PN; Weng MT; Tung CC; Yu LCH; Lai LC; Hsiao JH; Chuang EY; Shun CT; Ni YH; Xavier RJ; Podolsky DK; Yen JJY; Wong JM
    Inflamm Bowel Dis; 2017 Oct; 23(10):1730-1740. PubMed ID: 28906292
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic and pharmacological targeting of TPL-2 kinase ameliorates experimental colitis: a potential target for the treatment of Crohn's disease?
    Lawrenz M; Visekruna A; Kühl A; Schmidt N; Kaufmann SH; Steinhoff U
    Mucosal Immunol; 2012 Mar; 5(2):129-39. PubMed ID: 22157885
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fluoxetine inhibits hyperresponsive lamina propria mononuclear cells and bone marrow-derived dendritic cells, and ameliorates chronic colitis in IL-10-deficient mice.
    Koh SJ; Kim JW; Kim BG; Lee KL; Im JP; Kim JS
    Dig Dis Sci; 2015 Jan; 60(1):101-8. PubMed ID: 25146842
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Local delivery of adenoviral vectors encoding murine interleukin 10 induces colonic interleukin 10 production and is therapeutic for murine colitis.
    Lindsay JO; Ciesielski CJ; Scheinin T; Brennan FM; Hodgson HJ
    Gut; 2003 Mar; 52(3):363-9. PubMed ID: 12584217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oridonin derivative ameliorates experimental colitis by inhibiting activated T-cells and translocation of nuclear factor-kappa B.
    Liu QQ; Wang HL; Chen K; Wang SB; Xu Y; Ye Q; Sun YW
    J Dig Dis; 2016 Feb; 17(2):104-12. PubMed ID: 26718746
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling.
    Ge S; Yang Y; Zuo L; Song X; Wen H; Geng Z; He Y; Xu Z; Wu H; Shen M; Ge Y; Sun X
    Eur J Pharmacol; 2023 Feb; 940():175464. PubMed ID: 36566007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
    Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
    J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.
    Song J; Matsuda C; Kai Y; Nishida T; Nakajima K; Mizushima T; Kinoshita M; Yasue T; Sawa Y; Ito T
    J Pharmacol Exp Ther; 2008 Jan; 324(1):276-83. PubMed ID: 17898319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model.
    Yuan C; Chen WX; Zhu JS; Chen NW; Lu YM; Ou YX; Chen HQ
    Mediators Inflamm; 2013; 2013():617145. PubMed ID: 23690666
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
    Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Moxibustion combined with acupuncture increases tight junction protein expression in Crohn's disease patients.
    Shang HX; Wang AQ; Bao CH; Wu HG; Chen WF; Wu LY; Ji R; Zhao JM; Shi Y
    World J Gastroenterol; 2015 Apr; 21(16):4986-96. PubMed ID: 25945013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Roxithromycin inhibits nuclear factor kappaB signaling and endoplasmic reticulum stress in intestinal epithelial cells and ameliorates experimental colitis in mice.
    Choi Y; Koh SJ; Lee HS; Kim JW; Gwan Kim B; Lee KL; Kim JS
    Exp Biol Med (Maywood); 2015 Dec; 240(12):1664-71. PubMed ID: 26088864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral butyrate for mildly to moderately active Crohn's disease.
    Di Sabatino A; Morera R; Ciccocioppo R; Cazzola P; Gotti S; Tinozzi FP; Tinozzi S; Corazza GR
    Aliment Pharmacol Ther; 2005 Nov; 22(9):789-94. PubMed ID: 16225487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fenofibrate represses interleukin-17 and interferon-gamma expression and improves colitis in interleukin-10-deficient mice.
    Lee JW; Bajwa PJ; Carson MJ; Jeske DR; Cong Y; Elson CO; Lytle C; Straus DS
    Gastroenterology; 2007 Jul; 133(1):108-23. PubMed ID: 17631136
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adipokine apelin ameliorates chronic colitis in Il-10
    Ge Y; Li Y; Chen Q; Zhu W; Zuo L; Guo Z; Gong J; Cao L; Gu L; Li J
    Biochem Pharmacol; 2018 Feb; 148():202-212. PubMed ID: 29309764
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Synergistic effect of κ-carrageenan on oxazolone-induced inflammation in BALB/c mice.
    Wu W; Wang F; Gao X; Niu T; Zhu X; Yan X; Chen H
    BMC Gastroenterol; 2016 Mar; 16():41. PubMed ID: 27015810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-146b improves intestinal injury in mouse colitis by activating nuclear factor-κB and improving epithelial barrier function.
    Nata T; Fujiya M; Ueno N; Moriichi K; Konishi H; Tanabe H; Ohtake T; Ikuta K; Kohgo Y
    J Gene Med; 2013; 15(6-7):249-60. PubMed ID: 23813877
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The suppressive effect of triptolide on chronic colitis and TNF-alpha/TNFR2 signal pathway in interleukin-10 deficient mice.
    Wei X; Gong J; Zhu J; Wang P; Li N; Zhu W; Li J
    Clin Immunol; 2008 Nov; 129(2):211-8. PubMed ID: 18757245
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Chylomicrons-Simulating Sustained Drug Release in Mesenteric Lymphatics for the Treatment of Crohn's-Like Colitis.
    Yin Y; Yang J; Pan Y; Guo Z; Gao Y; Huang L; Zhou D; Ge Y; Guo F; Zhu W; Song Y; Li Y
    J Crohns Colitis; 2021 Apr; 15(4):631-646. PubMed ID: 32978613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arsenic trioxide reduces 2,4,6-trinitrobenzene sulfonic acid-induced murine colitis via nuclear factor-κB down-regulation and caspase-3 activation.
    Singer M; Trugnan G; Chelbi-Alix MK
    Innate Immun; 2011 Aug; 17(4):365-74. PubMed ID: 20693187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.